Many patients experience bowel and bladder toxicity during the acute phase of radiotherapy for prostate cancer. Recent literature indicates that hypofractionation (HF) might increase this acute response but little is known on patient-reported outcome during this phase with HF.
Background: With prostate cancer being the fifth-greatest cause of cancer mortality in 2020, there is a dire need to expand the available treatment options. Castration-resistant prostate cancer (CRPC) progresses despite androgen depletion therapy.
Previous studies indicated that location and amount of detected sentinel lymph nodes (SLNs) in prostate cancer (PCa) are influenced where SLN-tracer is deposited within the prostate. To validate whether intratumoral (IT) tracer injection helps to increase identification of tumor-positive lymph nodes (LNs) better than intraprostatic (IP) tracer injection, a prospective randomized phase II trial was […]
Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GvHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies, such as prostate, penile, and testicular cancer.
To better capitalize on our enhanced understanding of prostate cancer (PCa) risk factors, it is important to better understand how knowledge and attitudes contribute to ethnic disparities in PCa outcomes.
It has been recognized for decades that ERBB signaling is important in prostate cancer (PC), but targeting ERBB receptors as a therapeutic strategy for prostate cancer has been ineffective clinically.
Health-related quality of life (HRQoL) outcomes, in addition to being useful for monitoring a person’s health and well-being, may also predict overall survival (OS) in cancer patients. This study’s objective was to examine the association of longitudinally assessed HRQoL and OS in patients with a history of bladder cancer (BC).
During the past 2 decades, in order to improve perioperative and oncological outcomes, a minimally invasive approach, neoadjuvant chemotherapy (NAC), and an enhanced postoperative recovery program after surgery have been introduced into routine clinical practice of radical cystectomy (RC).
(UroToday.com) The Société Internationale D’Urologie (SIU) 2021 annual meeting included a plenary session with the EAU lecture provided by Dr. Arnulf Stenzl discussing comorbidity tailored treatment of prostate cancer. Dr. Stenzl started his presentation by highlighting that the EAU 22 meeting will be held, in person, in Amsterdam from March 18-21, 2022, with four full days […]
(UroToday.com) The Société Internationale D’Urologie (SIU) 2021 annual meeting included a plenary session with a State-of-the-Art lecture by Dr. Sia Daneshmand discussing new markers and the changing face of testicular cancer. Dr. Daneshmand started by highlighting that there are several challenges in testicular cancer, with several potential solutions:
